Organicell Regenerative Medicine, Inc. (OCEL) Stock Analysis

DELISTED

What happened to Organicell Regenerative Medicine, Inc. (OCEL) stock?

Organicell Regenerative Medicine, Inc. (OCEL) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades

MCap: $20.0M| Vol: 4.7K| 52-wk range: $0.896 – $4.80

Market cap $20.0M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Organicell Regenerative Medicine, Inc. (OCEL). Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing biological therapeutics for degenerative diseases. Their lead product, Zofin, is undergoing clinical trials for COVID-19 treatment and is derived from perinatal sources.

Last analyzed: Mar 17, 2026

Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing biological therapeutics for degenerative diseases. Their lead product, Zofin, is undergoing clinical trials for COVID-19 treatment and is derived from perinatal sources.

These figures come from statements filed 12 months ago — the most recent this company has published.

Organicell Regenerative Medicine, Inc. (OCEL) Healthcare & Pipeline Overview

Employees20

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 71% (not a measure of the evidence) Updated: Mar 17, 2026

OCEL OTC Market Information

OCEL trades on the OTC Other market tier of OTC Markets.

OTC Tier: OTC Other

Other OTC Other stocks

More about this archive record

Can I still buy OCEL shares?

No. OCEL stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for OCEL elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before OCEL stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Organicell Regenerative Medicine, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated Mar 17, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Mar 17, 2026.

Data provided for informational purposes only.